We found that the protein level of PRMT5 in ovarian cancer cells was significantly higher than that in normal proliferative cells (IOSE‐80 cells), although the mRNA level was only slightly increased (Figure 1D). This evidence concerns the gene PRMT5 and ovarian cancer.